Skip to content

NeuroOne Medical Technologies Corporation: 10-Q filed 2014-05-20

What NeuroOne Medical Technologies Corporation reported in its quarterly report filed 2014-05-20 (fiscal Q1 2014): 16 published measures, 45 facts as tagged in accession 0001144204-14-032425.

This filing

Form
10-Q (quarterly report)
Filed
2014-05-20
Fiscal period
fiscal Q1 2014
Accession
0001144204-14-032425 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NeuroOne Medical Technologies Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-03-31500USD
At 2013-12-31525USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-03-313,875USD
At 2013-12-3130,816USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-03-31-3,375USD
At 2013-12-31-30,291USD
At 2012-12-31-17,237USD
At 2011-12-31-3,277USD
At 2010-12-31-4,323USD
At 2009-12-31-1,221USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-4,228USD90
2009-08-20 to 2014-03-31-85,169USD1685
2013-01-01 to 2013-12-31-30,554USD365
2013-01-01 to 2013-03-31-3,308USD90
2012-01-01 to 2012-12-31-13,960USD366
2011-01-01 to 2011-12-31-27,604USD365
2010-01-01 to 2010-12-31-6,044USD365
2009-09-01 to 2009-12-31-2,779USD122

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-3,898USD90
2009-08-20 to 2014-03-31-78,975USD1685
2013-01-01 to 2013-03-31-2,985USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-03-31500USD
At 2013-12-31525USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-03-313,875USD
At 2013-12-3130,816USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-03-314,063USD90
2009-08-20 to 2014-03-3186,135USD1685
2013-01-01 to 2013-03-313,391USD90

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-03-31165USD90
2009-08-20 to 2014-03-317,160USD1685
2013-01-01 to 2013-03-31406USD90

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2009-08-20 to 2014-03-312,138USD1685

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-03-315,073,000shares
At 2013-12-315,073,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-03-3176,721USD
At 2013-12-3145,577USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-03-313,875USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-03-31188USD90
2009-08-20 to 2014-03-3129,919USD1685
2013-01-01 to 2013-03-313,391USD90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-03-31-330USD90
2009-08-20 to 2014-03-31-6,194USD1685
2013-01-01 to 2013-03-31-323USD90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2009-08-20 to 2014-03-3133,150USD1685
2013-01-01 to 2013-03-313,000USD90

Inspect the source

Entity
NeuroOne Medical Technologies Corporation / CIK 0001500198
Captured
2026-09-20T09:11:29.314Z
SEC response SHA-256
dec08ad6d59f8d84b3a6db4a6ff83df3a276b794fed82089495b0788055433dd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001500198.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))